Nov. 3, 2023 — Researchers have pioneered a novel treatment for the most common autoimmune encephalitis. By reprogramming white blood cells to target and eliminate ... The Quail Could Be the ...
Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...
AstraZeneca's supplemental Biologics License Application (sBLA) for IMFINZI® (durvalumab) has been accepted and granted Priority Review in the US for the treatment of patients with muscle-invasive ...